Napa Summit 2013 →
XSITE 2013 →
Founder and CEO, Isis Pharmaceuticals
Managing director, the Foundry Group
VP of Research and Special Initiatives, Google
Dir., Hillblom Center for the Biology of Aging, UC San Francisco
Senior Managing Partner, Aisling Capital Fund
CEO and Founder, oneforty, Inc.
CEO and Managing Partner, Flagship Ventures
Executive Director, Technology Alliance
Acetylon is developing targeted HDAC inhibitor drugs.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.